Characterization of neuropeptide Y receptor subtypes in the normal human brain, including the hypothalamus

Neuroscience
D JacquesR Quirion

Abstract

The aim of the present study was to investigate the existence and distribution of neuropeptide Y receptor subtypes in various regions of the normal human brain using the peptide YY derivative receptor probes, [125I][Leu31,Pro34]polypeptide YY/Y1 and [125I]polypeptide YY(3-36)/Y2, in addition to the non-selective ligand [125I]polypeptide YY. Membrane binding assays performed with post mortem frontal cortex homogenates revealed that [125I]polypeptide YY and [125I]polypeptide YY(3-36) bound in a time- and protein concentration-dependent manner. Very low amounts of specific [125I][Leu31,Pro34]polypeptide YY binding could be detected even in the presence of high amounts of protein, contrasting with results obtained with [125I]polypeptide YY and [125I]polypeptide YY(3-36), a preferential Y2 receptor probe. Analysis of saturation isotherms revealed that [125I]polypeptide YY(3-36) bound to a single class of high-affinity sites (0.5-2 nM). Significantly higher binding capacities were evident for [125I]polypeptide YY(3-36) as compared to [125I][Leu31,Pro34]polypeptide YY, suggesting that the human frontal cortex, in contrast to the rat, is mostly enriched with Y2 receptors. Ligand selectivity profile confirmed the hypothesis that polypep...Continue Reading

References

Jan 1, 1992·Progress in Neurobiology·Y DumontR Quirion
Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·H HerzogL A Selbie
Jan 1, 1991·British Journal of Pharmacology·W F ColmersK A Treherne
Sep 2, 1991·Neuroscience Letters·S A AicherC Wahlestedt
Oct 1, 1991·Trends in Pharmacological Sciences·M C Michel
Dec 4, 1990·European Journal of Pharmacology·Y DumontR Quirion
Dec 1, 1990·Cellular and Molecular Neurobiology·T OhkuboK Shigematsu
Jan 1, 1990·Annals of the New York Academy of Sciences·W F Colmers
Jan 1, 1990·Annals of the New York Academy of Sciences·R QuirionA Fournier
Jan 1, 1990·Annals of the New York Academy of Sciences·J E Morley, J F Flood
Jun 1, 1990·Journal of Medicinal Chemistry·M ForestA Fournier
Aug 22, 1985·The Journal of Comparative Neurology·V Chan-PalayJ M Polak
Oct 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·G TerenghiG Yasargil
Jan 1, 1989·Endocrinology·A InuiS Baba
Nov 1, 1986·Annals of Neurology·M F Beal, J B Martin
May 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·V Chan-PalayS L Palay
Aug 1, 1985·Neuroscience·B M ChronwallT L O'Donohue
Jul 1, 1985·Peptides·T L O'DonohueD A DiMaggio
Dec 8, 1983·Nature·T E AdrianJ M Polak
Jan 1, 1984·Cell and Tissue Research·G PelletierJ Cote
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·K Tatemoto

❮ Previous
Next ❯

Citations

Dec 23, 2003·Regulatory Peptides·Sara K S HolmbergDan Larhammar
Apr 6, 2005·Journal of Molecular and Cellular Cardiology·Mirna ChahineWolfgang Scholz
Oct 18, 2002·Life Sciences·John P RedrobeRémi Quirion
Mar 24, 1999·Trends in Neurosciences·A VezzaniW F Colmers
Oct 31, 1998·Brain Research. Molecular Brain Research·D JacquesR Quirion
Feb 29, 2000·British Journal of Pharmacology·Y Dumont, R Quirion
Mar 22, 2000·British Journal of Pharmacology·Y DumontR Quirion
Apr 7, 2005·Neuroreport·Anna Mari MäkeläHannu Tiitinen
Aug 2, 2003·British Journal of Sports Medicine·P F M AmaJ P Kamga
Oct 31, 2002·Reviews in the Neurosciences·Réne Garcia
Aug 21, 2015·Canadian Journal of Physiology and Pharmacology·Ghassan BkailyDanielle Jacques
Oct 8, 2015·Neuropeptides·R O TasanG Sperk
Sep 1, 2004·Neuropeptides·Sergueï O FetissovTomas Hökfelt
Sep 6, 2007·Endocrine Reviews·M M Kamiji, A Inui
Apr 15, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ana P SilvaJoão O Malva
May 13, 2005·International Journal of Immunopathology and Pharmacology·L BrunettiM Vacca
Mar 11, 2003·Experimental Biology and Medicine·Magnus M BerglundDonald R Gehlert
Feb 23, 2011·Natural Product Reports·Charles R RobertsonGrzegorz Bulaj

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.